Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
How to Architect a Presentation for an MSL Interview
Summary
In this episode, Tom Caravela welcomes guests Kendra Peltz and Josh Yoder, who share their unique journeys from wrestling backgrounds to becoming Medical Science Liaisons. They delve into the intricacies of MSL interview presentations, offering insights on preparation and execution. Kendra discusses her approach to creating impactful presentations, while Josh shares tips on crafting compelling narratives. The conversation covers the importance of following interview instructions, choosing the right topics, and mastering the Q&A session. The episode wraps up with advice for virtual presentations and a preview of future topics, encouraging listeners to subscribe for more insights.
My guests today are Josh Yoder, Regional Director and Kendra Pelz, MSL at Syneos Health and we discuss how to "architect" a presentation for an MSL interview
Josh and Kendra share…
👉 Types of presentations companies typically request
👉 Summary of Kendra’s presentation process for her last interview
👉 A framework for an interview presentation
👉 Types of questions that can be expected during the Q&A portion
👉 Tips on how to stand out in your presentation
Medical Science Liaisons, MSL interview presentations, virtual presentations, crafting compelling narratives, mastering Q&A session
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO